tirzepatide bulk Buy 10mg (GLP-1/GIP) FDA moves to remove GLP-1

One of the major trials of tirzepatide (the active ingredient in Zepbound and Mounjaro ) showed participants losing an average of 15%--21% of their body weight over a period of 72 weeks, with more weight loss in those taking the highest dose of the drug

That same study suggested that taking a GLP-1 for 1.5 years or more was associated with a 2.32 times higher chance of a deep vein thrombosis

"The vaccine seeks to protect severe outcomes associated with COVID-19

Signal Transduction and Targeted Therapy , 9 (1)

If considering discontinuation, understand what happens when you stop Wegovy to plan your long-term strategy